{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:00:39Z","timestamp":1791388839897,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neulet.2012.12.053","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T07:15:16Z","timestamp":1358320516000},"page":"69-73","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice"],"prefix":"10.1016","volume":"536","author":[{"given":"Jos\u00e9 L.","family":"Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrell","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Rayannavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Sealfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2012.12.053_bib0005","first-page":"29","article-title":"Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice","volume":"65C","author":"Ago","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0010","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/sj.npp.1301600","article-title":"Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2\/3 receptor agonist","volume":"33","author":"Benneyworth","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.107.035170","article-title":"A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis","volume":"72","author":"Benneyworth","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2008.06.089","article-title":"Behavioral characterization of the mGlu group II\/III receptor antagonist LY-341495, in animal models of anxiety and depression","volume":"592","author":"Bespalov","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molmed.2011.08.004","article-title":"Targeting glutamate synapses in schizophrenia","volume":"12","author":"Field","year":"2011","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.neulet.2012.12.053_bib0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2012.12.053_bib0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0893-133X(00)00136-6","article-title":"Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors","volume":"23","author":"Gewirtz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neulet.2012.12.053_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1756-6606-4-20","article-title":"GPCR oligomers in pharmacology and signaling","volume":"4","author":"Gonzalez-Maeso","year":"2011","journal-title":"Molecular Brain"},{"key":"10.1016\/j.neulet.2012.12.053_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2012.12.053_bib0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/092986709787581851","article-title":"Agonist-trafficking and hallucinogens","volume":"16","author":"Gonzalez-Maeso","year":"2009","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.neulet.2012.12.053_bib0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2008.12.005","article-title":"Psychedelics and schizophrenia","volume":"32","author":"Gonzalez-Maeso","year":"2009","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neulet.2012.12.053_bib0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2012.12.053_bib0070","first-page":"343","article-title":"Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation","volume":"98","author":"Jordan","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neulet.2012.12.053_bib0075","first-page":"48","article-title":"Role of BDNF\/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression","volume":"238C","author":"Koike","year":"2012","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neulet.2012.12.053_bib0080","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","volume":"15","author":"Kurita","year":"2012","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.neulet.2012.12.053_bib0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","article-title":"Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex","volume":"292","author":"Marek","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neulet.2012.12.053_bib0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neulet.2012.12.053_bib0095","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","article-title":"Identification of three residues essential for 5-HT2A-mGlu2 receptor heteromerization and its psychoactive behavioral function","volume":"287","author":"Moreno","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neulet.2012.12.053_bib0100","doi-asserted-by":"crossref","unstructured":"C. Muguruza, J.L. Moreno, A. Umali, L.F. Callado, J.J. Meana, J. Gonzalez-Maeso, Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects, European Neuropsychopharmacology, 2012, [Epub ahead of print].","DOI":"10.1016\/j.euroneuro.2012.10.006"},{"key":"10.1016\/j.neulet.2012.12.053_bib0105","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.neulet.2012.12.053_bib0110","doi-asserted-by":"crossref","first-page":"19762","DOI":"10.1074\/jbc.M110373200","article-title":"Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization","volume":"277","author":"Pfeiffer","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neulet.2012.12.053_bib0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrm2748","article-title":"Endocytosis and signalling: intertwining molecular networks","volume":"10","author":"Sorkin","year":"2009","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.neulet.2012.12.053_bib0125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.12.053_bib0130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.273.5275.645","article-title":"Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2","volume":"273","author":"Yokoi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.12.053_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.npp.1300013","article-title":"Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex","volume":"28","author":"Zhai","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401300013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439401300013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:18:33Z","timestamp":1745947113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030439401300013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":27,"alternative-id":["S030439401300013X"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2012.12.053","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}